Abstract LB-167: Phase I dose escalation study of abexinostat and doxorubicin in patients with metastatic sarcomas.:

  • Edwin Choy, Sriram Balasubramanian, James Butrynski, Jeffrey Morgan, Mint Sirisawad, Chitra Mani, Suzanne George, Andrew Wagner, David Harmon, Yael Rubinstein, Zhenfeng Duan, Francis Hornicek, George Demetri
  • Cancer Research, April 2013, American Association for Cancer Research (AACR)
  • DOI: 10.1158/1538-7445.am2013-lb-167

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1158/1538-7445.am2013-lb-167